Our blogs explain health conditions and clinical research in a way that is easy to follow, so readers can feel more informed
Nanotechnology Treatment Shows Promise Against Multiple Sclerosis
A nanotechnology treatment derived from bone marrow stem cells has reversed multiple sclerosis symptoms in mice and could eventually be used to help humans, according to a new study led by the University of California, Irvine researchers.
Genetic Marker Identified for Crohn’s Disease Drug Response
The largest study ever to look at why an expensive and commonly used group of drugs fails some patients with Crohn’s disease has identified a genetic marker that could individualize drug treatment. UK-Wide Collaboration and Study Findings A UK-wide collaboration led...
Stanford University Researchers Synthesize Scorpion Venom to Combat Drug-Resistant Tuberculosis Bacteria
Researchers at Stanford University and in Mexico have found that scorpion venom contains two color-changing compounds that could help fight bacterial infections. The potential pharmacological treasures awaiting discovery in the toxins of scorpions, snakes, snails and other poisonous creatures could lead to countless medical advancements.
Enhanced Human Blood-Brain Barrier Chip Performs in Vivo-Like Drug and Antibody Transport
This illustration shows how In the Blood-Brain-Barrier (BBB), thin endothelial capillaries (red) are wrapped by supporting pericytes (green) and astrocytes (yellow), enabling them to generate a tight barrier with highly selective transport functions for molecules entering the brain fluid from the...
First Human Ancestors Breastfed for Longer Than Contemporary Relatives
By analyzing the fossilized teeth of some of our most ancient ancestors, a team of scientists led by the universities of Bristol (UK) and Lyon (France) has discovered that the first humans significantly breastfed their infants for longer periods, revealing insights...
Chronic Enteroviral Infection Modifies Broadly Pancreatic Cellular Functions
Enteroviral infections, including chronic infections, are linked to type 1 diabetes onset. A study by the University of Turku and Tampere University confirms this association. Type 1 diabetes is a disorder in which the pancreatic insulin-producing beta-cells are destroyed, and it is...
How Memories Form and Fade
Why is it that you can remember the name of your childhood best friend that you haven’t seen in years yet easily forget the name of a person you just met a moment ago? In other words, why are some memories...
Designing a Blood Test That Can Predict Lifespan
The ability to predict how long someone is likely to live would help doctors tailor treatment plans. A new study looking at biomarkers in the blood concludes that more accurately estimating mortality might soon be possible. As it stands, doctors can...
Harvard Chemists’ Breakthrough in Synthesis Advances a Potent Anti-Cancer Agent
Harvard University chemists have achieved what a new paper calls a “landmark in drug discovery” with the synthesis of halichondrin. Known to be a potent anti-cancer agent in mouse studies, and found naturally in sea sponges. The halichondrin class of molecule...
A ‘One-Two Punch’ to Wipe Out Cancerous Ovarian Cells
Researchers from the University of Montreal Hospital Research Centre (CRCHUM) have developed a two-step combination therapy to destroy cancer cells. In a study published in the journal Nature Communications, they show the superior therapeutic effectiveness of the “one-two punch” on cells...
What Do Cros and Sponsor Consider When Selecting a Site?
Within the pharmaceutical industry, 45% of clinical trials are completed late, or 70%-80% of studies are delayed or do not meet their timelines. Due to these reasons, one of the main goals for a CRO is to create a mitigating strategy...
Chemists’ Breakthrough in Synthesis Advances a Potent Anti-cancer Agent
It’s a feat three decades in the making: Harvard University chemists have achieved what a new paper calls a “landmark in drug discovery” with the total synthesis of halichondrin. Known to be a potent anti-cancer drug therapy agent in mouse studies,...